These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29562462)

  • 1. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
    Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT.
    Yoshihara S; Maruya E; Taniguchi K; Kaida K; Kato R; Inoue T; Fujioka T; Tamaki H; Ikegame K; Okada M; Soma T; Hayashi K; Fujii N; Onuma T; Kusunoki Y; Saji H; Ogawa H
    Bone Marrow Transplant; 2012 Apr; 47(4):508-15. PubMed ID: 21691261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
    Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
    J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.
    Jaime-Pérez JC; Cruz MLR; Mendoza-Ibarra SI; Moncada-Saucedo NK; Gómez-Almaguer D
    Rev Invest Clin; 2023; 75(5):249-258. PubMed ID: 37918011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
    Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
    Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M
    Front Immunol; 2023; 14():1165759. PubMed ID: 37304258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.
    Bramanti S; Calafiore V; Longhi E; Mariotti J; Crespiatico L; Sarina B; De Philippis C; Nocco A; Santoro A; Castagna L
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1395-1406. PubMed ID: 30826463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
    Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of immunosuppression intensified conditioning regimen for patients with strong positive pre-transplantation donor-specific anti-HLA antibodies (DSAs) undergoing haploidentical hematopoietic stem cell transplantation].
    Liu HX; Wei DL; Shao S; Jiang Y; Li S; Zhu J; Wang C; Zhao CX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):654-659. PubMed ID: 37803839
    [No Abstract]   [Full Text] [Related]  

  • 10. Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders.
    Lima ACM; Bonfim C; Getz J; do Amaral GB; Petterle RR; Loth G; Nabhan SK; de Marco R; Gerbase-DeLima M; Pereira NF; Pasquini R
    Transplant Cell Ther; 2022 Oct; 28(10):698.e1-698.e11. PubMed ID: 35882362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection.
    Krummey SM; Gareau AJ
    Front Immunol; 2022; 13():916200. PubMed ID: 35990679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future directions in haploidentical hematopoietic stem cell transplantation.
    Vittayawacharin P; Kongtim P; Ciurea SO
    Hematology; 2024 Dec; 29(1):2366718. PubMed ID: 38889342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant.
    Zhu J; Wang Q; Liu Y; Dong Y; Liang Z; Yin Y; Liu W; Xu W; Sun Y; Wang B; Wang Q; Wang Q; Han N; Ren H; Li Y
    Int Immunopharmacol; 2023 Jul; 120():110299. PubMed ID: 37201405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
    Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
    Front Immunol; 2021; 12():674658. PubMed ID: 34093576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia].
    Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant
    Wang L; Ji K; Chen L; Li Y; Zhu W; Yuan X; Bao X; Wu X; He J
    Front Immunol; 2022; 13():1047200. PubMed ID: 36532004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
    Fürst S; Bernit E; Legrand F; Granata A; Harbi S; Devillier R; Maisano V; Bouchacourt B; Pagliardini T; Mokart D; Lemarié C; Calmels B; Picard C; Basire A; Andersson BS; Blaise D
    Bone Marrow Transplant; 2024 Jul; 59(7):918-927. PubMed ID: 38486114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood stem cells as third-party adjuvant infusions in human leukocyte antigen antibody-positive patients undergoing haploidentical hematopoietic stem cell transplantation.
    Wang Y; Zhao Y; Fang X; Yuan D; Ding M; Lu K; Qu H; Wang N; Lv X; Li P; Zhen C; Xu H; Jiang Y
    Front Immunol; 2024; 15():1459699. PubMed ID: 39399498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
    Choe H; Gergis U; Hsu J; Phillips A; Shore T; Christos P; van Besien K; Mayer S
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):e60-e64. PubMed ID: 30661542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming graft failure after haploidentical transplantation: Is this a possibility?
    Huang XJ
    Best Pract Res Clin Haematol; 2021 Mar; 34(1):101255. PubMed ID: 33762109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.